Tianxing Dai1, Lingrong Peng2, Guozhen Lin1, Yang Li1,3, Jia Yao1,3, Yinan Deng1,3, Hua Li1,3, Genshu Wang1,3, Wei Liu4, Yang Yang1,3, Guihua Chen3,4, Guoying Wang1,3. 1. Department of Hepatic Surgery and Liver Transplantation Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. 2. Department of Radiology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China. 3. Organ Transplantation Institute of Sun Yat-sen University, Guangzhou 510630, China. 4. Guangdong Key Laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Abstract
BACKGROUND: Elevated plasma fibrinogen has been reported to be associated with poor prognosis in several cancers. The aim of present study was to investigate the prognostic value of preoperative plasma fibrinogen in hepatocellular carcinoma (HCC) patients. METHODS: Data were collected retrospectively from 302 HCC patients who received hepatectomy. The association between fibrinogen and clinicopathological characteristics was evaluated. Both univariate and multivariate analyses were performed to identify prognostic factors for disease-free survival (DFS) and overall survival (OS). And accordingly, the nomograms were constructed. RESULTS: Elevated plasma fibrinogen (>4 g/L) was correlated with larger tumor diameter, the presence of vascular invasion, lower MELD score, higher NLR, advanced Barcelona Clinic Liver Cancer stage and poor-moderate pathological differentiation. On multivariate analysis, the elevated plasma fibrinogen was found independently associated with poor DFS (HR =1.575, P=0.024) and OS (HR =2.051, P=0.025). And the nomograms including fibrinogen were constructed to predict DFS and OS for HCC patients. Both DFS and OS in patients with plasma fibrinogen >4 g/L were significantly lower than those with fibrinogen ≤4 g/L (1-, 3-, 5-year DFS: 34.2%, 19.5% and 0.0% vs. 60.4%, 34.2% and 30.2%; 1-, 3-, 5-year OS: 83.4%, 62.7% and 48.8% vs. 95.4%, 84.3% and 75.8%, both P<0.001). Besides, subgroup analyses also showed the prognostic values of fibrinogen in HCC patients with/without cirrhosis or high AFP levels, and in those with single tumor and BCLC 0-A stage. CONCLUSIONS: Preoperative elevated plasma fibrinogen was an independent prognostic factor associated with poor prognosis in HCC patients receiving liver resection. 2019 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: Elevated plasma fibrinogen has been reported to be associated with poor prognosis in several cancers. The aim of present study was to investigate the prognostic value of preoperative plasma fibrinogen in hepatocellular carcinoma (HCC) patients. METHODS: Data were collected retrospectively from 302 HCC patients who received hepatectomy. The association between fibrinogen and clinicopathological characteristics was evaluated. Both univariate and multivariate analyses were performed to identify prognostic factors for disease-free survival (DFS) and overall survival (OS). And accordingly, the nomograms were constructed. RESULTS: Elevated plasma fibrinogen (>4 g/L) was correlated with larger tumor diameter, the presence of vascular invasion, lower MELD score, higher NLR, advanced Barcelona Clinic Liver Cancer stage and poor-moderate pathological differentiation. On multivariate analysis, the elevated plasma fibrinogen was found independently associated with poor DFS (HR =1.575, P=0.024) and OS (HR =2.051, P=0.025). And the nomograms including fibrinogen were constructed to predict DFS and OS for HCC patients. Both DFS and OS in patients with plasma fibrinogen >4 g/L were significantly lower than those with fibrinogen ≤4 g/L (1-, 3-, 5-year DFS: 34.2%, 19.5% and 0.0% vs. 60.4%, 34.2% and 30.2%; 1-, 3-, 5-year OS: 83.4%, 62.7% and 48.8% vs. 95.4%, 84.3% and 75.8%, both P<0.001). Besides, subgroup analyses also showed the prognostic values of fibrinogen in HCC patients with/without cirrhosis or high AFP levels, and in those with single tumor and BCLC 0-A stage. CONCLUSIONS: Preoperative elevated plasma fibrinogen was an independent prognostic factor associated with poor prognosis in HCC patients receiving liver resection. 2019 Journal of Gastrointestinal Oncology. All rights reserved.
Authors: Carla Jennewein; Nguyen Tran; Patrick Paulus; Peter Ellinghaus; Johannes Andreas Eble; Kai Zacharowski Journal: Mol Med Date: 2011-01-04 Impact factor: 6.354
Authors: A Duperray; L R Languino; J Plescia; A McDowall; N Hogg; A G Craig; A R Berendt; D C Altieri Journal: J Biol Chem Date: 1997-01-03 Impact factor: 5.157
Authors: Stephan Polterauer; Christoph Grimm; Veronika Seebacher; Nicole Concin; Christian Marth; Caroline Tomovski; Heinrich Husslein; Heinz Leipold; Katrin Hefler-Frischmuth; Clemens Tempfer; Alexander Reinthaller; Lukas Hefler Journal: Oncologist Date: 2009-09-23
Authors: M Z Wojtukiewicz; L R Zacharski; T E Moritz; K Hur; R L Edwards; F R Rickles Journal: Blood Coagul Fibrinolysis Date: 1992-08 Impact factor: 1.276
Authors: C Perisanidis; A Psyrri; E E Cohen; J Engelmann; G Heinze; B Perisanidis; A Stift; M Filipits; G Kornek; E Nkenke Journal: Cancer Treat Rev Date: 2015-12 Impact factor: 12.111
Authors: Glenys A Tennent; Stephen O Brennan; Arie J Stangou; John O'Grady; Philip N Hawkins; Mark B Pepys Journal: Blood Date: 2006-11-02 Impact factor: 22.113